Efficacy and Safety of Rituximab for Systemic Lupus Erythematosus-Associated Immune Cytopenias. A Multicenter Retrospective Cohort Study of 71 Adults
American Journal of Hematology - United States
doi 10.1002/ajh.24999
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 25, 2018
Authors
Publisher
Wiley